Search Results - "Brunson, M E"

Cancers after cyclosporine therapy by Penn, I, Brunson, M E

Get more information

Hepatitis C virus infection in kidney transplant recipients by Lau, J Y, Davis, G L, Brunson, M E, Qian, K P, Lin, H J, Quan, S, DiNello, R, Polito, A J, Scornik, J C

“…To determine the prevalence and significance of hepatitis C virus infection in kidney transplant recipients, paired serum samples collected from 100 renal…”
Get more information

The crossmatch in renal transplantation. Evaluation of flow cytometry as a replacement for standard cytotoxicity by Scornik, J C, Brunson, M E, Schaub, B, Howard, R J, Pfaff, W W

“…Flow cytometry (FC) is increasingly being used as a crossmatch procedure in addition to the standard complement-dependent cytotoxicity (CDC) test. In fact, FC…”
Get more information

Increased incidence of rejection in patients with delayed graft function by Howard, R J, Pfaff, W W, Brunson, M E, Scornik, J C, Ramos, E L, Peterson, J C, Fennell, R S, Croker, B P

“…Because of the difficulties in diagnosing rejection in patients with delayed graft function, such patients were routinely biopsied 7-10 days after kidney…”
Get more information

Roux-en-Y gastric bypass for recurrent nonalcoholic steatohepatitis in liver transplant recipients with morbid obesity by DUCHINI, Andrea, BRUNSON, Mathew E

“…Severe obesity is common before and after liver transplantation and has been associated with significant morbidity and mortality. Furthermore, it may cause…”
Get full text

A preliminary report of diltiazem and ketoconazole. Their cyclosporine-sparing effect and impact on transplant outcome by Patton, P R, Brunson, M E, Pfaff, W W, Howard, R J, Peterson, J C, Ramos, E L, Karlix, J L

“…A prospective randomized trial was conducted to compare the effect of diltiazem (DILT) with ketoconazole (KETO) on sparing of cyclosporine dose and renal…”
Get more information

Alloimmunization, memory, and the interpretation of crossmatch results for renal transplantation by Scornik, J C, Brunson, M E, Howard, R J, Pfaff, W W

Get more information

Transplantation of a hepatitis B surface antigen-positive donor liver into a hepatitis B virus-negative recipient by González-Peralta, R P, Andres, J M, Tung, F Y, Fang, J W, Brunson, M E, Davis, G L, Lau, J Y

“…A critically ill, HBV seronegative girl who received a liver from a HBsAg+ donor is described. Despite HBV Ig prophylaxis, she was seropositive for HBsAg…”
Get more information

Hyperacute and acute kidney graft rejection due to antibodies against B cells by Scornik, J C, LeFor, W M, Cicciarelli, J C, Brunson, M E, Bogaard, T, Howard, R J, Ackermann, J R, Mendez, R, Shires, Jr, D L, Pfaff, W W

“…Because of the perception of its uncertain clinical significance, the B cell crossmatch is not universally performed before renal transplantation. Even though…”
Get more information

Delayed graft function is associated with an increased incidence of occult rejection and results in poorer graft survival by Howard, R J, Pfaff, W W, Brunson, M E, Ramos, E L, Peterson, J C, Croker, B P, Scornik, J C, Parris, C J, Fennell, R S

Get more information

Psychological adjustment of liver transplant candidates by Rodrigue, J R, Davis, G L, Howard, R J, Brunson, M E, Langham, M R, Haiman, S, Behen, J

“…The psychological functioning of 20 adult liver transplant candidates was evaluated. Using standardized assessment instruments, we found few personality…”
Get more information

Kupffer cells can present alloantigen in vitro: an effect abrogated by gadolinium by Squiers, E C, Brunson, M E, Salomon, D R

“…Portal venous (PV) injection of alloantigen can result in tolerance. We have previously reported that this effect is abrogated by pretreatment with gadolinium…”
Get more information

HLA and Kaposi's sarcoma in solid organ transplantation by Brunson, M E, Balakrishnan, K, Penn, I

“…Of 188 cases of Kaposi's sarcoma arising de novo after transplantation, HLA-A, -B typing was available for 135 and HLA-DR typing available for 67. Compared to…”
Get more information

Enhancement of allograft survival by donor-specific transfusion one day prior to transplant. Importance of timing and specificity when DST is given with cyclosporine by Brunson, M E, Tchervenkov, J I, Alexander, J W

“…Donor-specific transfusion effects were studied in the ACI-to-Lewis rat heterotopic heart allograft model using cyclosporine immunosuppression. Low-dose CsA…”
Get more information

Lidocaine metabolism as an index of liver function in hepatic transplant donors and recipients by Schroeder, T J, Gremse, D A, Mansour, M E, Theuerling, A W, Brunson, M E, Ryckman, F C, Suchy, F J, Penn, I, Alexander, J W, Pesce, A J

Get more information

Relationship of the polymerase chain reaction for cytomegalovirus to the development of hepatitis in liver transplant recipients by Wolff, M A, Rand, K H, Houck, H J, Brunson, M E, Howard, R J, Langham, M R, Davis, G L, Mailliard, M E, Myers, B M, Andres, J

“…In a pilot study, the polymerase chain reaction was found to be more sensitive than standard viral culture methods for the detection of cytomegalovirus,…”
Get more information

Failure of azathioprine and steroids to augment one-day-pretransplant donor-specific transfusion-enhanced allograft survival by Madden, R L, Brunson, M E, Alexander, J W, Davies, C B

Get more information

A comparison of the clinical utility of the radioimmunoassay, high-performance liquid chromatography, and TDx cyclosporine assays in outpatient renal transplant recipients by Schroeder, T J, Brunson, M E, Pesce, A J, Hindenlang, L L, Mauser, P A, Ruckrigl, D I, Weibel, M L, Wadih, G, First, M R

“…Rapid and precise cyclosporine measurements are necessary to maximize immunosuppression and minimize toxicity. The new cyclosporine and metabolites TDx…”
Get more information

Mechanisms of transfusion-induced immunosuppression by Brunson, M E, Alexander, J W

Get more information

Effect of various prokinetic agents on post Roux-en-Y gastric emptying: experimental and clinical observations by HOCKING, M. P, BRUNSON, M. E, VOGEL, S. B

“…The effect of various prokinetic drugs was assessed in animals with Roux-en-Y gastrojejunostomy. The agents tested were (1) bethanechol 2.5 mg subcutaneously…”
Get full text